| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 422.64M | 409.62M | 297.53M | 465.04M | 608.07M | 492.59M |
| Gross Profit | 52.09M | 49.72M | 20.18M | 53.87M | 121.68M | 4.44M |
| EBITDA | 31.11M | 30.77M | 32.49M | 29.25M | 77.29M | -27.25M |
| Net Income | 13.45M | 2.98M | -2.36M | -6.56M | 47.71M | -93.10M |
Balance Sheet | ||||||
| Total Assets | 1.27B | 1.21B | 1.05B | 1.02B | 989.38M | 878.88M |
| Cash, Cash Equivalents and Short-Term Investments | 389.27M | 308.88M | 208.13M | 295.22M | 154.51M | 167.14M |
| Total Debt | 222.55M | 186.40M | 86.90M | 54.02M | 58.43M | 4.61M |
| Total Liabilities | 378.29M | 335.97M | 182.37M | 136.21M | 113.98M | 66.28M |
| Stockholders Equity | 887.38M | 874.86M | 872.37M | 879.49M | 869.87M | 812.60M |
Cash Flow | ||||||
| Free Cash Flow | -7.65M | 22.33M | 20.33M | 197.79M | -111.53M | 60.73M |
| Operating Cash Flow | 6.47M | 33.47M | 24.41M | 204.99M | -98.32M | 60.73M |
| Investing Cash Flow | -84.40M | -132.32M | -143.73M | -160.44M | -43.78M | -789.00K |
| Financing Cash Flow | 100.90M | 96.43M | 36.80M | -547.00K | 57.92M | -385.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | HK$87.39M | 5.79 | 1.51% | ― | 38.42% | ― | |
52 Neutral | HK$168.89M | 10.00 | 20.69% | 8.93% | -13.44% | ― | |
48 Neutral | HK$56.00M | -1.23 | -112.69% | ― | -20.21% | -39.66% | |
44 Neutral | HK$162.34M | -2.37 | -39.50% | ― | -32.54% | 71.35% | |
42 Neutral | HK$16.24M | -3.40 | -49.85% | ― | -7.75% | 37.65% | |
39 Underperform | HK$190.23M | -6.94 | ― | ― | -50.43% | 79.67% |
China Environmental Technology and Bioenergy Holdings Limited announced a clarification regarding its share award scheme, specifying that after the recent grant of share awards, 3,705 shares remain available for future grants under the 2025 Share Award Scheme. This announcement provides clarity on the company’s share distribution strategy, potentially impacting its market positioning and shareholder value.
The most recent analyst rating on (HK:1237) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on China Environmental Technology and Bioenergy Holdings Limited stock, see the HK:1237 Stock Forecast page.
China Environmental Technology and Bioenergy Holdings Limited announced the grant of 9,600,000 share awards to 11 selected employees under its 2025 Share Award Scheme. This initiative aims to retain and reward employees for their contributions, align their interests with shareholders, and support the company’s long-term growth. The share awards, which have no performance targets, are designed to enhance employee commitment and attract high-caliber personnel, with a clawback mechanism in place for cases of fraud or misconduct.
The most recent analyst rating on (HK:1237) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on China Environmental Technology and Bioenergy Holdings Limited stock, see the HK:1237 Stock Forecast page.
China Environmental Technology and Bioenergy Holdings Limited announced that all proposed resolutions were successfully passed at their Extraordinary General Meeting held on October 16, 2025. The resolutions, which include the approval of the 2025 Share Award Scheme and the Service Provider Sublimit, received overwhelming support from shareholders, with over 99% of votes in favor. This outcome reflects strong shareholder confidence and positions the company favorably for future strategic initiatives.
The most recent analyst rating on (HK:1237) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on China Environmental Technology and Bioenergy Holdings Limited stock, see the HK:1237 Stock Forecast page.